If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
ASX 200's Highest-Paid CEOs: Who Leads the Pack?
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
ResMed Price Target Raised 1.6% to A$35.40/Share by Macquarie
ResMed Earnings Preview: What to Expect
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
ResMed Price Target Raised to $204.00/Share From $200.00 by RBC Capital
RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $204
ResMed Analyst Ratings
RBC Raises Price Target on ResMed to $204 From $200, Keeps Sector Perform Rating
Express News | Resmed Inc : RBC Raises Target Price to $204 From $200
Australian Stocks With U.S. Exposure Could Be a 'Trump Trade' Bet -- Market Talk
UBS Adjusts ResMed Price Target to $210 From $195, Maintains Neutral Rating
Express News | Resmed Inc : UBS Raises Target Price to $210 From $195
Do Weight Loss Drugs Pose a Threat to ResMed Shares?
VARON Enters CPAP and BiPAP Machine Market With Feature-Rich "Sunny Grand" Series
Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Buy Resmed Shares at 'Attractive Entry Level' Says Top Broker
Why the ResMed Share Price Tanked in FY 2024 and What to Expect in FY 2025
Eli Lilly's GLP-1 Impact on ResMed Is Overblown: Barron's
No Data